Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
RANI

Rani Therapeutics Holdings (RANI) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $0.80 +0.9% on the day +67.5% over 12 months 52-week range $0.46 – $2.85

Share price and insider trades

RANI closeInsider buyInsider sale
0123NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $301 on 2026-03-27 · Alireza JavadiBought $24,840 on 2026-07-21 · Mir A ImranBought $25,200 on 2026-07-17 · Talat ImranBought $1,270,834 on 2025-10-23 · Mir A ImranSold $4,634,430 on 2025-10-20 · South Cone Investments Limited PartnershipSold $11,080,000 on 2025-10-21 · South Cone Investments Limited Partnership
Bought, 12 months$1.3M
Sold, 12 months$15.7M
Insiders buying2
Insiders selling3

Rani Therapeutics Holdings insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $1.3M and 3 sold $15.7M of RANI stock on the open market.

RANI insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $1.3M bought (1 trades)$1.3MQ4 2025: $15.7M sold (2 trades)Q4 2025Q1 2026: $301 sold (1 trades)Q1 2026Q2 2026Q3 2026: $50K bought (2 trades)$50KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$50K2—0
Q2 2026—0—0
Q1 2026—0$3011
Q4 2025$1.3M1$15.7M2

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit+$400KOn all tracked purchases +30.3%

Summary

Over the past 12 months, 2 Rani Therapeutics Holdings, Inc. insiders reported open-market purchases totaling $1.3M, while 3 insiders reported sales totaling $15.7M. 0 of 4 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jul 23SEC Mir A ImranDirector Buy 36,0002,119,334 held (+2%) $0.69 $25K +15.8% —
Jul 21SEC Talat ImranCEO Buy 35,000469,736 held (+8%) $0.72 $25K +11.0% —
Jul 21SEC Talat ImranCEO Sell 8,014486,737 held (−2%) $1.41 $11K -43.3% —
Jul 21SEC Alireza JavadiChief Technical Officer Sell 3869,689 held (−4%) $0.78 $301 +2.4% —
Oct 27SEC Mir A ImranDirector Buy 2,083,334new position $0.61 $1.3M +31.0% —
Oct 22SEC South Cone Investments Limited Partnership10% Owner Sell 4,000,0002,379,194 held (−63%) $2.77 $11.1M -71.2% —
Oct 22SEC South Cone Investments Limited Partnership10% Owner Sell 1,923,0006,379,194 held (−23%) $2.41 $4.6M -66.8% —

Insiders at Rani Therapeutics Holdings, Inc.

InsiderBoughtSoldLast filingScore
South Cone Investments Limited Partnership10% Owner — $15.7M Oct 22, 2025 —
Mir A ImranDirector $1.3M — Jul 23, 2026 —
Talat ImranCEO $25K $11K Jul 21, 2026 —
Alireza JavadiChief Technical Officer — $301 Jul 21, 2026 —

RANI stock: common questions

Are Rani Therapeutics Holdings, Inc. insiders buying RANI stock?

In the past 12 months, 2 insiders reported open-market purchases of RANI worth $1.3M. The latest was Director Mir A Imran bought $25K of RANI at $0.69.

Are Rani Therapeutics Holdings, Inc. insiders selling RANI stock?

3 insiders reported sales worth $15.7M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is RANI's 52-week range?

Over the past year RANI has traded between $0.46 and $2.85. It last closed at $0.80 on Oct 9, 2026.